𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mechanisms Underlying the Process of Demyelination in Multiple Sclerosis

✍ Scribed by T. A. Pivneva


Publisher
Springer US
Year
2009
Tongue
English
Weight
282 KB
Volume
41
Category
Article
ISSN
0090-2977

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Monoclonal antibody treatment exposes th
✍ Alasdair J. Coles; Mark G. Wing; Paul Molyneux; Andrea Paolillo; Charlie M. Davi πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 186 KB πŸ‘ 2 views

The elective treatment of patients with multiple sclerosis, using a humanized anti-leukocyte (CD52) monoclonal antibody (Campath-1H), has illuminated mechanisms that underlie the clinical course of the disease. Twenty-seven patients were studied clinically and by magnetic resonance imaging (MRI) bef

Galactosylceramide: A reliable serum ind
✍ C. Lubetzki; Y. Thuillier PharmD; A. Galli PharmD; O. Lyon-Caen; F. Lhermitte; D πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 295 KB πŸ‘ 2 views

This difference may be attributable to the degeneration of cholinergic neurons in the basal ganglia in PSP but not in Parkinson's disease 131. The extrapyramidal A Reliable Serum Index of Demyelination in Multiple response to physostigmine could serve as an early means to differentiate these two dis

Unfolding the long-term pathophysiologic
✍ Wafaa Zaaraoui; Audrey Rico; Bertrand Audoin; FranΓ§oise Reuter; Irina Malikova; πŸ“‚ Article πŸ“… 2010 πŸ› Elsevier Science 🌐 English βš– 967 KB

## Background: Acute symptomatic inflammation is a main feature of multiple sclerosis but pathophysiological processes underlying total or partial recovery are poorly understood. ## Objective: To characterize in vivo these processes at molecular, structural and functional levels using multimodal